Close
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Logo
Logo
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home IT Management
    • IT Management
    • Mobile

    FDA Task Force Releases RFID Recommendations

    Written by

    Renee Boucher Ferguson
    Published June 9, 2006
    Share
    Facebook
    Twitter
    Linkedin

      eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.

      The Food and Drug Administrations Counterfeit Drug Task Force announced June 9 its recommendations for the pharmaceutical industry regarding the use of radio-frequency identification technology to fight the proliferation of some 35 million counterfeit drugs in America.

      The report recommends that the FDA remove its “hold” on its so-called pedigree act, reinstating the 2007 deadline for those in the pharmaceutical supply chain to implement some form of electronic tracking technology, be that RFID, bar codes or a combination of both.

      While the Task Force didnt actually mandate the use of RFID to track and trace drugs through the pharmaceutical distribution chain—from manufacturer to wholesaler to retailer to consumer—it did point to RFID as “the most promising technology for implementing electronic track and trace in the drug supply chain,” and suggested that “stakeholders move quickly to implement this technology.”

      The concept of utilizing RFID to track drugs stems from the FDAs 1987 Prescription Drug Marketing Act that requires drug distributors to provide a “pedigree” for pharmaceuticals—documentation of the chain of custody of drug products.

      In 1999 the FDA published its final PDMA regulations, which were to take effect the following year.

      After a lot of negative feedback—from trade associations and from Congress—the FDA delayed the effective date until 2001.

      With little impact on changing practices along the supply chain, in 2004 the FDA again delayed the provision—this time until December 2006.

      The latest deadline was set “because we were informed by stakeholders in the U.S. drug supply chain that industry would adopt electronic track and trace technology by 2007,” according to Fridays report.

      The thought was that when widely adopted, the new technology—RFID—would create a sort of de facto e-pedigree standard that would amount to documenting the movement of drugs.

      While an industry-wide adoption of RFID by 2007 hasnt actually panned out, during a fact-finding mission in 2006 the Task Force found that what had once been considered an onerous undertaking—developing an electronic drug pedigree—might not be that difficult, according to the June 9 report.

      However, the Task Force is not pushing the 2007 deadline.

      “We continue to believe that RFID is the most promising technology for electronic track and trace across the drug supply chain. However, we recognize that the goals can also be achieved by using other technologies, such as 2D barcodes,” the report states.

      “Based on what we have recently heard, we are optimistic that the hybrid environment of electronic/paper and the use of RFID/bar code is achievable in the very near future.”

      /zimages/5/28571.gifClick here to read more about pharmaceutical RFID adoption.

      The report, however, cautions that RIFD is not a panacea for the problem of tracking counterfeit drugs.

      It lists a number of big issues to overcome including: a lack of standards (e-pedigree fields and format, data systems, international transmission and hardware specifications); privacy concerns; concerns about the ownership of confidential business transaction data; challenges in serializing products; concerns over the speed and accuracy of electronic devices and systems; and a lack of definitive data to determine how RFID will affect sensitive products like liquids and biologics.

      Next Page: Growing controversy.

      Growing Controversy

      While there has been growing controversy in consumer advocate groups over a number of areas the Task Force highlighted (privacy and security chief among them), vendors have also had battles regarding standards.

      One brouhaha is over whether HF (high frequency) or the newer UHG (ultra high frequency) is the better tag and reader frequency on which industries should standardize—particularly in the case of tagging sensitive drugs.

      The fear with UHF, which is based on the Gen 2 standard for tags and readers, is that the electricity generated from the reader to the tag during a read would be similar to popping a cup of coffee in the microwave for too long.

      Proponents of UHF, primarily vendors looking to implement Gen 2 in their products, say the claims are bunk. On June 8 a consortium of companies—ADT/Tyco Fire & Security, Alien, Impinj, Intel, Symbol and Xterprise—sponsored a white paper meant to dispel myths about UHF vs. HF.

      In summary, the FDA Task Force made a number of recommendations to those along the pharmaceutical supply chain: that they continue moving forward in implementing RFID; that they consider a phased-in approach to RFID, targeting high-value and high-theft drugs first; and that stakeholders explore the use of RFID for tracking medical countermeasures.

      At the same time, the report recommends that the FDA work with industry, standards organizations and others to facilitate RFID implementation, and that it move to quickly to complete its own RFID Impact Study—and publicly share the results.

      /zimages/5/28571.gifTo read more about the FDAs guidelines on pharmaceutical RFID, click here.

      The report also has some significant recommendations privacy and data encryption.

      In addition to forming its own task force to test RFID, the report recommends the FDA create an industry-wide label pointing out RFID-tagged drugs, and that it commit resources to a public education program on RFID.

      “Privacy issues are a real concern for consumers and FDA. These concerns will continue unless there is appropriate disclosures of the presence of an RIFD tag on containers given to patients and sufficient education about the application, true risks, benefits and vulnerabilities associated with RFID on drug products,” reads the report. “This is no easy task.”

      /zimages/5/28571.gifCheck out eWEEK.coms for the latest news, reviews and analysis on mobile and wireless computing.

      Renee Boucher Ferguson
      Renee Boucher Ferguson

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      MOST POPULAR ARTICLES

      Artificial Intelligence

      9 Best AI 3D Generators You Need...

      Sam Rinko - June 25, 2024 0
      AI 3D Generators are powerful tools for many different industries. Discover the best AI 3D Generators, and learn which is best for your specific use case.
      Read more
      Cloud

      RingCentral Expands Its Collaboration Platform

      Zeus Kerravala - November 22, 2023 0
      RingCentral adds AI-enabled contact center and hybrid event products to its suite of collaboration services.
      Read more
      Artificial Intelligence

      8 Best AI Data Analytics Software &...

      Aminu Abdullahi - January 18, 2024 0
      Learn the top AI data analytics software to use. Compare AI data analytics solutions & features to make the best choice for your business.
      Read more
      Latest News

      Zeus Kerravala on Networking: Multicloud, 5G, and...

      James Maguire - December 16, 2022 0
      I spoke with Zeus Kerravala, industry analyst at ZK Research, about the rapid changes in enterprise networking, as tech advances and digital transformation prompt...
      Read more
      Video

      Datadog President Amit Agarwal on Trends in...

      James Maguire - November 11, 2022 0
      I spoke with Amit Agarwal, President of Datadog, about infrastructure observability, from current trends to key challenges to the future of this rapidly growing...
      Read more
      Logo

      eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site’s focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Advertisers

      Advertise with TechnologyAdvice on eWeek and our other IT-focused platforms.

      Advertise with Us

      Menu

      • About eWeek
      • Subscribe to our Newsletter
      • Latest News

      Our Brands

      • Privacy Policy
      • Terms
      • About
      • Contact
      • Advertise
      • Sitemap
      • California – Do Not Sell My Information

      Property of TechnologyAdvice.
      © 2024 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×